Minerva Neurosciences (NERV) Amount of Cash per Share

Corporate emblem and logo of Minerva (NERV)

Minerva Neurosciences (NERV) is developing scientific partnerships with pharmaceutical behemoths to create drugs for psychiatric disorders. The key driver remains the FDA approval of roluperidone, which would confirm the efficacy of schizophrenia therapy. The company is currently executing a complex strategic pivot, addressing regulatory comments during new trials. The fluctuations in cash per share shown on GURU.Markets demonstrate liquidity, where the 1.56 indicator determines the magnitude of the metric.

NERV Minerva Neurosciences Corp: Cash Funds per Share in the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Minerva Neurosciences Inc (NERV)

- price and consensus price forecast:
- cash position and cash flow details:
Summary company analysis:NERV (Minerva)
Signature product of Minerva Neurosciences, Inc.

This indicator determines the volume of liquid assets per share, reflecting the issuer's actual cash resilience. An increase in this metric indicates financial discipline, whereas stagnation may signal inefficient capital management. By analyzing cash per security, an investor assesses the business's margin of safety. For Minerva Neurosciences (NERV), this resource is critically important for funding the salaries of leading neurobiologists. A stable liquidity balance guarantees support for costly research into schizophrenia therapies.

Analysis of competing companies

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|alteritytherapeutics.com (ATHE) - Cash Funds per Share|Cash per Single Share Clene Nanomedicine|Cash per Single Share PEPG|Cash on Hand per Share Jupiter Neurosciences JUNS|Cash Funds per Share Relmada (RLMD)|Cash Funds Calculated per Share Annovis Bio, Inc.|Cash per Share GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cash on Hand per Share|KLTO - Cash Funds per Share|Cash on Hand per Share NeuroSense Therapeutics Ltd|RVPH: Cash per Share|MetaVia, Inc. (MTVA) - Cash per Share|Cash Funds per Share NeurAxis|Cash per Share heliusmedical.com|Cash per Single Share PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Cash Funds per Single Share|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share